The kinetics of hybrid formation between the RNA of BrdU-activated endogenous guinea pig virus and the DNA of leukemic, normal, or BrdU-activated guinea pig cells were measured by the technique of RNA. DNA hybridization in DNA excess. The results suggest that virus-specific sequences representing some 60-70% of the viral genome are unique (2-3 copies per haploid cell genome), while the remainder (30-40%) are reiterated (147 copies), and that the reiterated virus-specific DNA may be composed of more than one species, each having a different reiteration frequency. No difference was found in the quantity of viral DNA sequences contained in normal, leukemic, or bromodeoxyuridine-activated guinea pig cells. These data are considerably different from those reported for exogenous; (infectious) oncornaviruses, where cells infected or transformed by exogenous RNA tumor viruses have been shown to contain increased amounts of virus-specific DNA. The data reported here are consistent with the contention that preexisting viral genes are activated by bromodeoxyuridine treatment. Results of hybridization experiments done at different DNA/RNA ratios suggest that although the virus-specific DNA is partly unique and partly reiterated, the viral RNA does not contain any detectable internal reiteration. Total mass of the viral RNA sequences is around 0.7 to 1 X 107 daltons.
Since we reported that leukemic chicken myeloblasts contained increased amounts of oncornavirus-specific DNA (v-DNA) when compared to normal cells (1, 2) , a number of investigators have confirmed and extended these observations to other systems (3) (4) (5) 9) . In our initial studies, an excess of viral RNA from avian myeloblastosis virus (AMV) was hybridized with the DNA of myeloblastosis virus-producing leukemic chicken myeloblasts and with the DNA of normal chicken embryos immobilized on filters (1, 2) . Since then, however, a more refined methodology of quantitating virusspecific DNA has developed. Such procedures usually investigate the kinetics by which radioactively labelled viral probes (RNA or DNA) reassociate with excess cellular DNA. Except in a few cases (6) (7) (8) , increases in v-DNA have been reported in cells infected with exogenous RNA tumor viruses. This increase has been observed in both virus-producing cells, whether or not they are transformed, and in transformed nonvirus-producing cells (3, 11) . Baxt and Spiegelman, using the techniques of molecular hybridization, have demonstrated DNA sequences in human leukemic cells which are absent in nonleukemic cells (10) . Such a finding is consistent with the idea that an exogenous virus may bring new information into leukemic cells, even though these cells are not producing viruses.
During these studies, it became obvious that even DNA from normal cells is homologous to some oncornavirusspecific sequences (1) (2) (3) (4) (5) (6) (7) (8) (9) 11) . Although normally repressed, these viral genes can be activated to produce virus in a number of ways (12) (13) (14) (15) (16) (17) . These activated viruses, known as endogenous viruses, are mostly noninfectious for the host in which they are induced. They possess the same morphological, physical, and biochemical properties as exogenous (infectious) viruses. Their role in malignancy is uncertain at present.
We have recently activated and characterized an endogenous oncornavirus (GPV) from cultured guinea pig cells (17) which do not have any known infectious (exogenous) oncornaviruses. In this report, evidence is presented which suggests that unlike exogenous RNA tumor viruses, the amount of virus-specific DNA in cells induced to produce an endogenous virus does not increase. In fact, the same amount of viral DNA was found in normal, leukemic and bromodeoxyuridine (BrdU)-induced (virus producing) guinea pig cells.
MATERIALS AND METHODS
Animals and Cells. Random bred and inbred Wright's strain 2 guinea pigs were obtained from Curd's Caviary (Los Angeles). Leukemia is maintained in strain 2 guinea pigs by transplanting leukemic cells into healthy animals. Animals inoculated in this way develop leukemia within [2] [3] [4] weeks. Leukemic animals with a white cell count of 2 to 3 X 105/mm3 were bled by cardiac puncture and only the leukemic blood cells were used in these experiments. Over 95% of these cells were leukemic lymphoblasts. The methodology involved in establishing cultures from guinea pig embryos or adult leukemic animals has been described previously (17) .
Activation of Endogenous Guinea Pig Oncornavirus by BrdU. As reported previously (17) , nonconfluent cultures were treated with BrdU (10-4 M) for 24 (17) . For 2 days the labeled medium was changed every [4] [5] [6] hr.
Isolation of Labeled GPV and GPV-RNA. GPV was concentrated and purified in sucrose gradients as described previously (17) . Viral RNA was purified from the peak virus fractions by the phenol-sodium dodecyl sulfate method (18 (23, 24) . The kinetics of hybridization of cRNA with guinea pig DNA are also shown in Fig. 1 . The maximum hybridization of cRNA was 58% of the input. There was no hybrid formation below a Cot of 500, indicating that rapidly reassociating DNA was not transcribed in vitro. Self-annealing of cRNA was less than 1%. As expected, the rate of hybridization of cRNA to DNA (Kh) was slower than the reassociation rate (Kd). The Coth,/2of guinea pig cRNA was 6000 [extrapolating the hybridization curve ( Fig. 1) Fig. 2 . The curve shows the position of reference graph of cRNA plotted from Fig. 1 (---) . and E. coli DNA. High-molecular-weight viral RNA (65-70 S) alone, or in the presence of E. coli or chicken DNA, formed only 2-4% RNase resistance (Fig. 2) . The kinetics of hybrid formation between GPV-[3H]RNA and normal or leukemic guinea pig DNA suggest two points of consideration ( Fig. 2) (19, 27, 29) . The plateau of the reiterated portion may be masked either by the trailing effect of the unique portion or because of multiple DNA segments within the reiterated DNA, each with a different reiterated frequency. In either case, it is almost impossible to estimate the frequency of reiterated v-DNA sequences precisely. Thus, the value of reiteration frequency of 147 is merely an average estimate rather than the actual number of DNA copies.
In spite of these limitations, it is obvious that there is no difference in the RNA -DNA hybridization kinetics of leukemic lymphoblasts and normal embryos (Fig. 2) . These data indicate that v-DNA representing the entire viral genome is found in both normal and leukemic cells, and that it is composed of species with identical reiteration frequency (Fig. 2 ). This conclusion was derived from two independent experi- Reference curve of cRNA hybridization is drawn from Fig. 1 (---). 70S GLV-RNA with a specific activity of 875,000 cpm/.ug was used.
ments (each using DNA from both normal and leukemic cells) (Fig. 2) . In addition, no difference was found between the virus-specific DNA content of the cultured guinea pig cells and guinea pig embryo (not shown here).
The next experiments consider if the activation of virus by BrdU requires amplification of viral DNA. First, we ensured that the majority of cells after BrdU treatment are producing viruses. In our conditions, the entire population became characteristically altered by the fourth day of BrdU treatment (guinea pig embryo fibroblasts became flattened and enlarged with increased cytoplasm). In the electron microscope, over 50%O of cells contained characteristic vacuoles and virus particles. Similar effects of BrdU treatment in guinea pig cells have been reported by others (16) . Hybridization results of GPV-RNA and DNA from normal and BrdU-induced guinea pig cells are shown in Fig. 3 . The reference graph of cRNA hybridization is plotted for comparison. The hybridization rate again shows that the same amount of viral DNA was present in both uninduced and BrdU-activated virus-producing cells. Thus, it appears that GPV-DNA is not amplified in cells actively producing GPV particles.
Next, Gross leukemic virus (GLV) RNA was hybridized with mouse and guinea pig cell DNA (Fig. 4) (Fig. 4) . This lack of homology between the GLV-RNA and guinea pig DNA also indicates that guinea pig virus is not related to murine viruses. Indeed, the common group specific mammalian viral antigen (gs-3) has not been detected in normal, leukemic or BrdU-activated guinea pig cells (ref. 25 (27) to determine the mass and the frequency of hemoglobin genes.
In Fig. 5 , one first observes a drop in hybrid formation (I) at a high DNA/RNA ratio. This drop is followed by a plateau and a second drop (II) of hybrid formation at a relatively low DNA/RNA ratio. Several conclusions can be drawn from these results: (1) Assuming that 100% of viral RNA will hybridize to guinea pig DNA at a very high DNA/RNA ratio, the initial drop (I) represents about 60% of the viral genome (Fig. 5) . Since this rapid drop of hybrid formation occurs at a relatively high DNA/RNA ratio, DNA sequences complementary to this portion of viral RNA are unique in guinea pig cells. Indeed, this part of the viral DNA (60%) corresponds fairly close to the value (65%) obtained from Fig. 2 for the unique region. (2) (5) The mass of RNA sequences can be calculated using a predetermined reiteration frequency according to the following equation of Bishop et al. (27, 28) :
where M = mass of a single-stranded RNA sequence in daltons; mass Nd/N? is the ratio of viral DNA to viral RNA; C is the analytical complexity of the haploid cellular genome; F is the frequency of reiteration; D/R is an overall DNA/RNA ratio (as seen on the abscissa) (Fig. 5) . Assuming that 100% of RNA will hybridize at a high Nd/N, (i.e., >20), the value of Nd/N7 at 50% hybrid formation is estimated to be around 2.0 (27, 28) . Therefore, at 50% hybrid formation Eq. 1 becomes: [2] where D/R (50) is the overall DNA/RNA ratio at 50% hybridization. Eq. 2 can be used to estimate the mass of RNA corresponding to the unique and the reiterated portion of v-DNA from Fig. 5 . For the portion of v-RNA which hybridizes with the unique DNA, D/R (50) = 3.5 X 105 (Fig. 5) extrapolating the curve to 100%, the mass of the RNA will be either 3.5 X 10' or 5.3 X 10' daltons for F 3 or 2, respectively.
As for the portion of the viral genome which hybridizes with the reiterated v-DNA sequences, there is difficulty in estimating the mass because the reiteration frequency 147 could not be determined accurately (Fig. 2) . However, an independent frequency estimate of 140 for the reiterated DNA relative to that of the unique DNA was derived from Fig. 5 . Thus, the mass of the viral RNA corresponding to the reiterated v-.DNA is either 5.3 or 3.5 X 10' daltons when F = 2 or 3 X 140 aild D/R (50) = 2500. If the reiteration frequency of 147 (Fig. 2) is used the estimated mass of the RNA sequences corresponding to the reiterated v-DNA will be much higher (107 daltons). In either case, this precludes the possibility of detecting any internal reiteration within the viral RNA because it will require that the calculated mass of RNA se- RNA was isolated from BrdU-activated GPV. Varied amounts of unlabeled GPV-RNA were added to the mixture of a constant amount of labeled GPV-RNA and guinea pig embryo DNA. All hybridization was carried out as described in Fig. 2 (5, 29) . Data in Fig. 5 further show that there is little if any internal reiteration within the viral RNA.
Technical factors which limit the precise frequency estimation of a DNA sequence have been described by others (27) (28) (29) .
However, these limitations do not have a significant bearing on our overall conclusion that there is no quantitative difference in the amount of virus-specific DNA in normal, leukemic and BrdU-treated guinea pig cells. The kinetics of hybrid forma-tion between GPV-RNA and cellular DNA were the same for either leukemic, normal or BrdU-treated cells over a Cot of 5 decades. Our results are then considerably different from the ones reported in the case of cells infected or transformed by exogenous oncornaviruses (1) (2) (3) (4) (5) .
There are three obvious explanations to account for the absence of any increase virus-specific DNA sequences in normal, leukemic and Brdtl-treated cells. (1) Endogenous virus genes are not expressed in leukemic or BrdU-treated cells. (2) The expression of GPV-genome does not require any amplification or additional synthesis of new DNA. (3) The rates of synthesis and decay of virus-specific DNA sequences are the same; and, therefore, there will not be any net increase in the amount of DNA. It is obvious that the entire virus genome is expressed in BrdU-treated cells since BrdUactivated viral RNA is used as the probe. Evidence which will be presented elsewhere indicates that the GPV genome is also expressed in leukemic cells. This evidence is based on: (a) noninfectious particles morphologically resembling GPV are consistently present in leukemic cells (33) (34) (35) ; (b) leukemic plasma pellets contain both virus particles and a DNA polymerase (33, 37) ; (c) fresh leukemic cells placed in culture release particles which have a density of 1.16 g/ml in a sucrose gradient and possess an oncornavirus-specific reverse transcriptase; and (d) GPV-RNA, undetectable in normal cells, is present in leukemic cells. The third possibility of a high turnover rate of DNA is unlikely and without any known precedent.
Absence of increased v-DNA sequence in BrdU-activated cells also supports that the virus production after BrdU treatment is due to the activation of repressed v-DNA sequences and not to the facilitation of infection. It is conceivable that a few cells are chronically infected and release virus at an undetectable level. The majority of the cells which are normally resistant to virus infection become susceptible after BrdU treatment. If this was the case, more v-DNA copies per cell would be found in BrdU-induced cells because oncornaviruses which contain an RNA-dependent DNA polymerase (reverse transcriptase) (31, 32) replicate via a DNA intermediate (30) . If 
